How can European startups master the coronavirus crisis? Is the innovation ecosystem on the Old Continent healthy enough to weather the pandemic and, perhaps, emerge from the lockdown stronger than before? Are investors adventurous enough to finance groundbreaking ideas? What role do the EU and local governments play in speeding up digital transformation?
In a DLD Sync session moderated by Handelsblatt Deputy Editor Sebastian Matthes, Lakestar founder Klaus Hommels and Merck Group CEO Stefan Oschmann took a close look at Europe’s competitive advantages – and shortcomings – in a fast-changing global economy. Key insights follow below, along with a video recording of this wide-ranging, thought-provoking conversation about a business landscape that may forever be changed by the Covid-19 pandemic.
Dr. Klaus Homels is Founder of Lakestar. As a leading European business angel and venture capitalist, Hommels has been involved in numerous successful Internet investments – including Skype, Facebook, Airbnb, King.com, Xing and Spotify. He scouts for promising start-ups that have the potential to become category leaders in technology. He was ranked as one of the top Europe-based venture capital investors in 2013, 2014 and 2015 on Forbes Magazine’s Midas List.
Stefan Oschmann is CEO and Chairman of the Executive Board at Merck. Before taking office at the end of April 2016, he served as the pharmaceutical company’s Vice Chairman and Deputy CEO, with responsibility for Group Strategy, among other things. Stefan Oschmann drove the transformation of the biopharma business by optimizing its cost structures and improving the efficiency of its research & development model, which included a clear portfolio prioritization. He started his career at an agency of the United Nations and worked for the German Chemical Industry Association (VCI).
Sebastian Matthes, moderator of this session, is Deputy Editor-in-Chief and Head of Digital at Handelsblatt, Germany’s leading business daily publication. Previously he was editor-in-chief of HuffPost Germany and wrote for WirtschaftsWoche, Financial Times Germany and Neue Züricher Zeitung, among others. He also teaches at universities and journalism schools, such as Hamburg media School.
Biotech: Europe’s Best Shot?
In the hunt for a vaccine protecting us from the novel coronavirus, two companies from Germany have drawn worldwide attention, Stefan Oschmann noted: Both CureVac and BioNTech are leaders in a field of research named mRNA therapeutics. The technology in essence uses molecules synthetically designed to prompt the body to heal itself.
A medical trial by U.S. biotech startup Moderna seemed to show the potential of this approach to quickly develop a Covid-19 vaccine. While some experts cautioned that the trial had severe limitations, Oschmann was confident that this field of research holds great promise.
“In biotech, I believe, Europe will be a hotspot”, the Merck CEO said, calling mRNA therapeutics “a revolutionary technology” that could be used to fight cancer as well as epidemics. “If we’re super lucky we may have a vaccine later this year”, Oschmann said. “If we’re just lucky we may have a vaccine around this time next year.”
He also warned, however, that a vaccine “will not be used in mass administration early on”. Instead it would likely be restricted to high-risk groups of the population while manufacturers ramp up production.
Preparing For A Comeback
The pandemic may have badly affected many companies large and small, Klaus Hommels observed; but when it comes to recovering from the crisis, technology-driven firms have a clear advantage. “Digital infrastructures allow these companies to react very quickly to changes”, the Lakestar founder said.
A company like travel startup GetYourGuide – part of Lakestar’s investment portfolio – could, for example, easily shift spending from marketing to product development, Hommels suggested, only to emerge stronger from the crisis. “When everything opens up again these companies will win”, Hommels predicted. “And they will win at the cost of incumbent players.”
In addition, Hommels sees the pandemic serving as a catalyst for digital transformation. “There are a lot people who were reluctant to get into this digital business and are now forced to go into this digital business”, Hommels said. (A sentiment also expressed by Sir Martin Sorrell in a recent DLD Sync session.) The winners of this trend, digital service providers of all sorts, benefit from having “no customer acquisition cost” and “loyal, long-lasting customers coming onboard”, Hommels observed.
Much of Europe’s economic success currently rests on the shoulders of industrial giants – from car and train manufacturers to producers of chemicals, pharmaceuticals and consumer goods. But what about digital services, artificial intelligence and other future-forward technologies?
“We do have 1,500 world market leaders in [the small and medium business sector] and we’re very strong in academia”, Klaus Hommels said. “But we haven’t had a decent funding environment.” Success stories like Spotify and Zalando were largely due to special circumstances, he pointed out, advocating a more deliberate push in European venture investment – particularly to grow future digital champions.
Stefan Oschmann agreed, calling for a change in regulation to make it easier for institutional investors to participate in venture capital funding. Investing in startups was naturally risky, he admitted, “but it’s not more risky than other investments if you take a basket approach to it”.
More money, however, was not enough, Oschmann said. Europe also needed to provide better support to entrepreneurs and corporations. “There are plenty of good ideas in Europe”, Oschmann said. “What is lacking is a dedicated government policy and a coherent innovation ecosystem in which people cooperate without borders.”
On the upside, he added, the pandemic was clearly having a positive effect in this regard, driving the idea home that science and business need to interact more closely in Europe. “My impression is that this crisis was a major wake-up call for our politicians in that respect”, Oschmann said.
Besides biotech, quantum computing could turn out to be a driver of growth for the European economy, Stefan Oschmann suggested. “I think Europe has a chance to become a major player in this area”, he said, adding that Merck had invested in a number of startups in this field through its own venture fund.
The search for meat alternatives was another field of opportunity that both speakers singled out. “I think there’s a lot of future in food technology because if we want to make a [positive] impact on the environment we really need to think differently”, Oschmann said. Lakestar, which recently raised some 700 million euros for future investments, was also looking at this field, Klaus Hommels added.
Asked how the coronavirus crisis had changed their lives on a personal level, both executives agreed that video conferencing had positively surprised them. “We made investments where we didn’t meet the founders in real life”, Klaus Hommels said – something he had never considered possible before the pandemic-induced lockdown. “I do believe this is here to stay, rather than being an exception.”
Similarly, Stefan Oschmann explained how he had successfully switched from flying around the world to mastering various video-conferencing tools, keeping in touch with colleagues and business partners in different time zones on a daily basis. “I don’t think it’s completely sustainable”, he said, “but I was absolutely surprised how well that works.”
Watch the full DLD Sync session with Klaus Hommels and Stefan Oschmann, moderated by Sebastian Matthes.
The easy way to rediscover your favorite moments of the talk.
|0:05||Intro by DLD founder Steffi Czerny.|
|4:10||Europe’s economy tomorrow: hot or not?|
|5:15||The initial effect of the coronavirus crisis for Merck and Lakestar.|
|6:45||Timeline for a vaccine.|
|8:15||Three groups of tech companies and their fate due to Covid-19.|
|11:20||Why technology-driven companies have an edge.|
|12:15||The crisis as an opportunity for Europe’s tech ecosystem.|
|13:55||Will Europe’s current interest in biotech last?|
|16:30||Making the most of Europe’s strengths.|
|19:25||Fostering collaboration between public and private sector. Taking a cue from Israel and other countries.|
|20:15||The upside potential hidden in Europe’s healthcare system.|
|22:15||The lack of a “decent funding environment”.|
|24:50||How risky is the venture capital business?|
|27:45||The value of venture capital to the overall economy.|
|31:25||Plenty of good ideas – but no coherent innovation system.|
|34:45||The crisis as a wake-up call.|
|39:00||Quantum computing, food, liquid crystals: potential breakthrough technologies for Europe.|
|43:30||The need to “upgrade the public healthcare sector”.|
|45:50||Staying agile: fostering an innovation culture at large companies.|
|51:30||The surprising benefits of video conferencing.|
More DLD Sync
NYU Prof. Scott Galloway explains why the coronavirus pandemic is likely to make tech companies even more powerful and change entire sectors of the economy…